Loading…
Could steroids be withdrawn in renal transplant patients sequentially treated with ATG, cyclosporine, and cellcept? One-year results of a double-blind, randomized, multicenter study comparing normal dose versus low-dose and withdrawal of steroids. M 55002 French Study Group
Saved in:
| Published in: | Transplantation proceedings 2000-03, Vol.32 (2), p.396-397 |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , |
| Format: | Article |
| Language: | English |
| Subjects: | |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| cited_by | |
|---|---|
| cites | |
| container_end_page | 397 |
| container_issue | 2 |
| container_start_page | 396 |
| container_title | Transplantation proceedings |
| container_volume | 32 |
| creator | Lebranchu, Y Aubert, P Bayle, F Bedrossian, J Berthoux, F Bourbigot, B Buchler, M Chalopin, J M Deteix, P Glotz, D Huraut De Ligny, B Kessler, M Lang, P Lefrancois, N Le Pogamp, P Moulin, B Mourad, G Olmer, M Sraer, J D Touchard, G Toupance, O Wolf, P Puget, S |
| description | |
| format | article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_70970317</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>70970317</sourcerecordid><originalsourceid>FETCH-LOGICAL-p542-f92f61f20d4c744ad4b89fdf6704dae1128519e8cad54771f1f363469bef8f643</originalsourceid><addsrcrecordid>eNo1kU9P3DAQxVOpqFDohQ9QzamnTWUnTrI5VWgF20ogDux95djjYuTYrv90FT59zZY9eUb6-b15Mx-rC0IYrWnLuvPqc4wvpPQNaz9V55QMtGNdc_HheuOykRATBqdlhAnhoNOzDPxgQVsIaLmBFLiN3nCbwPOk0aYIEf_kUmhuzFIA5Anl8S_c7LYrEIswLnoXtMUVcCtBoDECffoBjxbrBXko6jGbouUUcJAuTwbryWgrV1AcpZv1K5Z6LpAWxQxDmTTLBYSbPS_Sv8G6MJcJpYsIfzHEHMG4Q33s31xPaQpTXE45v8MDdB0hDdyVhOIZno6y2-Cyv6rOFDcRv7y_l9Xu7na3-VnfP25_bW7ua9-xplZjo3qqGiKZGBjjkk3rUUnVD4RJjpQ2646OuBZcdmwYqKKq7VvWjxOqtepZe1l9-y_rgyubjGk_6_i2I27R5bgfyDiQlg4F_PoO5mlGufdBzzws-9MR23_9xJ2D</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>70970317</pqid></control><display><type>article</type><title>Could steroids be withdrawn in renal transplant patients sequentially treated with ATG, cyclosporine, and cellcept? One-year results of a double-blind, randomized, multicenter study comparing normal dose versus low-dose and withdrawal of steroids. M 55002 French Study Group</title><source>ScienceDirect Freedom Collection</source><creator>Lebranchu, Y ; Aubert, P ; Bayle, F ; Bedrossian, J ; Berthoux, F ; Bourbigot, B ; Buchler, M ; Chalopin, J M ; Deteix, P ; Glotz, D ; Huraut De Ligny, B ; Kessler, M ; Lang, P ; Lefrancois, N ; Le Pogamp, P ; Moulin, B ; Mourad, G ; Olmer, M ; Sraer, J D ; Touchard, G ; Toupance, O ; Wolf, P ; Puget, S</creator><creatorcontrib>Lebranchu, Y ; Aubert, P ; Bayle, F ; Bedrossian, J ; Berthoux, F ; Bourbigot, B ; Buchler, M ; Chalopin, J M ; Deteix, P ; Glotz, D ; Huraut De Ligny, B ; Kessler, M ; Lang, P ; Lefrancois, N ; Le Pogamp, P ; Moulin, B ; Mourad, G ; Olmer, M ; Sraer, J D ; Touchard, G ; Toupance, O ; Wolf, P ; Puget, S</creatorcontrib><identifier>ISSN: 0041-1345</identifier><identifier>PMID: 10715452</identifier><language>eng</language><publisher>United States</publisher><subject>Adrenal Cortex Hormones - administration & dosage ; Adrenal Cortex Hormones - therapeutic use ; Antilymphocyte Serum - therapeutic use ; Cyclosporine - therapeutic use ; Drug Administration Schedule ; Drug Therapy, Combination ; Follow-Up Studies ; France ; Humans ; Immunosuppressive Agents - therapeutic use ; Kidney Transplantation - immunology ; Mycophenolic Acid - analogs & derivatives ; Mycophenolic Acid - therapeutic use ; Time Factors</subject><ispartof>Transplantation proceedings, 2000-03, Vol.32 (2), p.396-397</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10715452$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lebranchu, Y</creatorcontrib><creatorcontrib>Aubert, P</creatorcontrib><creatorcontrib>Bayle, F</creatorcontrib><creatorcontrib>Bedrossian, J</creatorcontrib><creatorcontrib>Berthoux, F</creatorcontrib><creatorcontrib>Bourbigot, B</creatorcontrib><creatorcontrib>Buchler, M</creatorcontrib><creatorcontrib>Chalopin, J M</creatorcontrib><creatorcontrib>Deteix, P</creatorcontrib><creatorcontrib>Glotz, D</creatorcontrib><creatorcontrib>Huraut De Ligny, B</creatorcontrib><creatorcontrib>Kessler, M</creatorcontrib><creatorcontrib>Lang, P</creatorcontrib><creatorcontrib>Lefrancois, N</creatorcontrib><creatorcontrib>Le Pogamp, P</creatorcontrib><creatorcontrib>Moulin, B</creatorcontrib><creatorcontrib>Mourad, G</creatorcontrib><creatorcontrib>Olmer, M</creatorcontrib><creatorcontrib>Sraer, J D</creatorcontrib><creatorcontrib>Touchard, G</creatorcontrib><creatorcontrib>Toupance, O</creatorcontrib><creatorcontrib>Wolf, P</creatorcontrib><creatorcontrib>Puget, S</creatorcontrib><title>Could steroids be withdrawn in renal transplant patients sequentially treated with ATG, cyclosporine, and cellcept? One-year results of a double-blind, randomized, multicenter study comparing normal dose versus low-dose and withdrawal of steroids. M 55002 French Study Group</title><title>Transplantation proceedings</title><addtitle>Transplant Proc</addtitle><subject>Adrenal Cortex Hormones - administration & dosage</subject><subject>Adrenal Cortex Hormones - therapeutic use</subject><subject>Antilymphocyte Serum - therapeutic use</subject><subject>Cyclosporine - therapeutic use</subject><subject>Drug Administration Schedule</subject><subject>Drug Therapy, Combination</subject><subject>Follow-Up Studies</subject><subject>France</subject><subject>Humans</subject><subject>Immunosuppressive Agents - therapeutic use</subject><subject>Kidney Transplantation - immunology</subject><subject>Mycophenolic Acid - analogs & derivatives</subject><subject>Mycophenolic Acid - therapeutic use</subject><subject>Time Factors</subject><issn>0041-1345</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2000</creationdate><recordtype>article</recordtype><recordid>eNo1kU9P3DAQxVOpqFDohQ9QzamnTWUnTrI5VWgF20ogDux95djjYuTYrv90FT59zZY9eUb6-b15Mx-rC0IYrWnLuvPqc4wvpPQNaz9V55QMtGNdc_HheuOykRATBqdlhAnhoNOzDPxgQVsIaLmBFLiN3nCbwPOk0aYIEf_kUmhuzFIA5Anl8S_c7LYrEIswLnoXtMUVcCtBoDECffoBjxbrBXko6jGbouUUcJAuTwbryWgrV1AcpZv1K5Z6LpAWxQxDmTTLBYSbPS_Sv8G6MJcJpYsIfzHEHMG4Q33s31xPaQpTXE45v8MDdB0hDdyVhOIZno6y2-Cyv6rOFDcRv7y_l9Xu7na3-VnfP25_bW7ua9-xplZjo3qqGiKZGBjjkk3rUUnVD4RJjpQ2646OuBZcdmwYqKKq7VvWjxOqtepZe1l9-y_rgyubjGk_6_i2I27R5bgfyDiQlg4F_PoO5mlGufdBzzws-9MR23_9xJ2D</recordid><startdate>200003</startdate><enddate>200003</enddate><creator>Lebranchu, Y</creator><creator>Aubert, P</creator><creator>Bayle, F</creator><creator>Bedrossian, J</creator><creator>Berthoux, F</creator><creator>Bourbigot, B</creator><creator>Buchler, M</creator><creator>Chalopin, J M</creator><creator>Deteix, P</creator><creator>Glotz, D</creator><creator>Huraut De Ligny, B</creator><creator>Kessler, M</creator><creator>Lang, P</creator><creator>Lefrancois, N</creator><creator>Le Pogamp, P</creator><creator>Moulin, B</creator><creator>Mourad, G</creator><creator>Olmer, M</creator><creator>Sraer, J D</creator><creator>Touchard, G</creator><creator>Toupance, O</creator><creator>Wolf, P</creator><creator>Puget, S</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>200003</creationdate><title>Could steroids be withdrawn in renal transplant patients sequentially treated with ATG, cyclosporine, and cellcept? One-year results of a double-blind, randomized, multicenter study comparing normal dose versus low-dose and withdrawal of steroids. M 55002 French Study Group</title><author>Lebranchu, Y ; Aubert, P ; Bayle, F ; Bedrossian, J ; Berthoux, F ; Bourbigot, B ; Buchler, M ; Chalopin, J M ; Deteix, P ; Glotz, D ; Huraut De Ligny, B ; Kessler, M ; Lang, P ; Lefrancois, N ; Le Pogamp, P ; Moulin, B ; Mourad, G ; Olmer, M ; Sraer, J D ; Touchard, G ; Toupance, O ; Wolf, P ; Puget, S</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p542-f92f61f20d4c744ad4b89fdf6704dae1128519e8cad54771f1f363469bef8f643</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2000</creationdate><topic>Adrenal Cortex Hormones - administration & dosage</topic><topic>Adrenal Cortex Hormones - therapeutic use</topic><topic>Antilymphocyte Serum - therapeutic use</topic><topic>Cyclosporine - therapeutic use</topic><topic>Drug Administration Schedule</topic><topic>Drug Therapy, Combination</topic><topic>Follow-Up Studies</topic><topic>France</topic><topic>Humans</topic><topic>Immunosuppressive Agents - therapeutic use</topic><topic>Kidney Transplantation - immunology</topic><topic>Mycophenolic Acid - analogs & derivatives</topic><topic>Mycophenolic Acid - therapeutic use</topic><topic>Time Factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lebranchu, Y</creatorcontrib><creatorcontrib>Aubert, P</creatorcontrib><creatorcontrib>Bayle, F</creatorcontrib><creatorcontrib>Bedrossian, J</creatorcontrib><creatorcontrib>Berthoux, F</creatorcontrib><creatorcontrib>Bourbigot, B</creatorcontrib><creatorcontrib>Buchler, M</creatorcontrib><creatorcontrib>Chalopin, J M</creatorcontrib><creatorcontrib>Deteix, P</creatorcontrib><creatorcontrib>Glotz, D</creatorcontrib><creatorcontrib>Huraut De Ligny, B</creatorcontrib><creatorcontrib>Kessler, M</creatorcontrib><creatorcontrib>Lang, P</creatorcontrib><creatorcontrib>Lefrancois, N</creatorcontrib><creatorcontrib>Le Pogamp, P</creatorcontrib><creatorcontrib>Moulin, B</creatorcontrib><creatorcontrib>Mourad, G</creatorcontrib><creatorcontrib>Olmer, M</creatorcontrib><creatorcontrib>Sraer, J D</creatorcontrib><creatorcontrib>Touchard, G</creatorcontrib><creatorcontrib>Toupance, O</creatorcontrib><creatorcontrib>Wolf, P</creatorcontrib><creatorcontrib>Puget, S</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Transplantation proceedings</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lebranchu, Y</au><au>Aubert, P</au><au>Bayle, F</au><au>Bedrossian, J</au><au>Berthoux, F</au><au>Bourbigot, B</au><au>Buchler, M</au><au>Chalopin, J M</au><au>Deteix, P</au><au>Glotz, D</au><au>Huraut De Ligny, B</au><au>Kessler, M</au><au>Lang, P</au><au>Lefrancois, N</au><au>Le Pogamp, P</au><au>Moulin, B</au><au>Mourad, G</au><au>Olmer, M</au><au>Sraer, J D</au><au>Touchard, G</au><au>Toupance, O</au><au>Wolf, P</au><au>Puget, S</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Could steroids be withdrawn in renal transplant patients sequentially treated with ATG, cyclosporine, and cellcept? One-year results of a double-blind, randomized, multicenter study comparing normal dose versus low-dose and withdrawal of steroids. M 55002 French Study Group</atitle><jtitle>Transplantation proceedings</jtitle><addtitle>Transplant Proc</addtitle><date>2000-03</date><risdate>2000</risdate><volume>32</volume><issue>2</issue><spage>396</spage><epage>397</epage><pages>396-397</pages><issn>0041-1345</issn><cop>United States</cop><pmid>10715452</pmid><tpages>2</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0041-1345 |
| ispartof | Transplantation proceedings, 2000-03, Vol.32 (2), p.396-397 |
| issn | 0041-1345 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_70970317 |
| source | ScienceDirect Freedom Collection |
| subjects | Adrenal Cortex Hormones - administration & dosage Adrenal Cortex Hormones - therapeutic use Antilymphocyte Serum - therapeutic use Cyclosporine - therapeutic use Drug Administration Schedule Drug Therapy, Combination Follow-Up Studies France Humans Immunosuppressive Agents - therapeutic use Kidney Transplantation - immunology Mycophenolic Acid - analogs & derivatives Mycophenolic Acid - therapeutic use Time Factors |
| title | Could steroids be withdrawn in renal transplant patients sequentially treated with ATG, cyclosporine, and cellcept? One-year results of a double-blind, randomized, multicenter study comparing normal dose versus low-dose and withdrawal of steroids. M 55002 French Study Group |
| url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-21T04%3A11%3A14IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Could%20steroids%20be%20withdrawn%20in%20renal%20transplant%20patients%20sequentially%20treated%20with%20ATG,%20cyclosporine,%20and%20cellcept?%20One-year%20results%20of%20a%20double-blind,%20randomized,%20multicenter%20study%20comparing%20normal%20dose%20versus%20low-dose%20and%20withdrawal%20of%20steroids.%20M%2055002%20French%20Study%20Group&rft.jtitle=Transplantation%20proceedings&rft.au=Lebranchu,%20Y&rft.date=2000-03&rft.volume=32&rft.issue=2&rft.spage=396&rft.epage=397&rft.pages=396-397&rft.issn=0041-1345&rft_id=info:doi/&rft_dat=%3Cproquest_pubme%3E70970317%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-p542-f92f61f20d4c744ad4b89fdf6704dae1128519e8cad54771f1f363469bef8f643%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=70970317&rft_id=info:pmid/10715452&rfr_iscdi=true |